Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Dionex Corporation - DNEX
16 12월 2010 - 6:31AM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Dionex Corporation (“Dionex” or the “Company”)
(NasdaqGS: DNEX) for potential breaches of fiduciary duties in
connection with their conduct related to the sale of the Company to
Thermo Fisher Scientific Inc. (NYSE: TMO) for an estimated $2.1
billion. The proposed transaction offers Dionex shareholders to
only receive $118.50 in cash. The proposed transaction is expected
to close in the first quarter of 2011.
Request more information now by clicking here:
www.faruqilaw.com/DNEX
Whether the Dionex’s Board of Directors breached their fiduciary
duties to Dionex’s stockholders by failing to conduct an adequate
and fair sales process to sell the Company prior to agreeing to
this proposed transaction, whether the proposed transaction
undervalues Dionex’s shares and by how much this proposed
transaction undervalues the Company to the detriment of Dionex
shareholders are the key focus of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, through all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in Dionex and wish to obtain additional
information, please visit us at www.faruqilaw.com/DNEX or contact
Juan E. Monteverde, Esq. either via e-mail at
jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or
(212) 983-9330.
Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Dionex Corp. (MM) (NASDAQ:DNEX)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Dionex Corp. (MM) (NASDAQ:DNEX)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
Dionex Corp. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Faruqi & Faruqi, LLP News Articles